And our last session led by Gaelle Mercenne on “drugging the undruggable” for our last panel discussion on deck to wrap up our first annual #regulomesummit
Talus Bio
@talusbio.bsky.social
Talus Bio is a venture-backed early-stage biotechnology startup company working on drug development for gene regulators.
Thread🧵to continue these discussions on enabling AI/ML in drug discovery here following the #regulomesummit panel discussion. Great conversations led by @willfondrie.com Next up keynote by Prof Steven Henikoff
Next up, we have Jeff Leek of Synthesize Bio kicking off the AI/ML session at our #regulomesummit!
Session on patient and clinical perspectives from the Northwest Sarcoma Foundation starting up now led by Gaelle Mercenne! #regulomesummit
@willfondrie.com discussing how we use AI and ML to further drug discovery here at Talus Bio. Come check it out to learn more! #regulomesummit
@lindsaykpino.com talking about the power of using proteomics to measure the regulome of live cells using our platform here at Talus Bio, and how far we have been able to scale this platform up to further cancer drug discovery and more. #regulomesummit
Regulome summit opening remarks are kicking off now! Lots more to come today, come check it out!
Regulome Summit kicks off in 20 minutes! We have food, coffee, marmots, posters, and lots of great content coming up. Stop by Dempsey Hall on UW campus to learn about gene regulation, nuclear proteomics, and AI-driven drug discovery!
